Abstract
Background: Chondrodystrophic myotonia or Schwartz-Jampel syndrome is a rare genetic disorder characterized by myotonia and skeletal dysplasia. It may be progressive in nature. Recently, the gene responsible for Schwartz-Jampel syndrome has been found and the defective protein it encodes leads to abnormal cartilage development and anomalous neuromuscular activity. Case Presentation: We report the clinical findings and the management of an 8-year-old boy with this disorder. The molecular findings confirm that the patient is a compound heterozygote with a different splicing mutation in each Perlecan allele. This resulted in a significant reduction in the production of the encoded normal protein. Conclusion: We discuss the multi-disciplinary management of Schwartz-Jampel syndrome that will facilitate optimal care and timely intervention of patients with this disorder. © 2003 Ho et al; licensee BioMed Central Ltd.
Cite
CITATION STYLE
Ho, N. C., Sandusky, S., Madike, V., Francomano, C. A., & Dalakas, M. C. (2003). Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): A case report. BMC Neurology, 3. https://doi.org/10.1186/1471-2377-3-3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.